Publication | Closed Access

Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial

Gene TherapiesOncologyGliomaPathologyOperable High-grade GliomaSitimagene CeradenovecHigh-grade GliomasCancer TreatmentMedicineRadiation OncologyNovel TherapyViral OncologyAdenovirus-mediated Gene TherapyCancer-associated Virus